CAS: 30806-83-8; Ethyl 4-Isocyanatobenzoate

该化合物是一种有机化合物,其特征为异丙烯酯功能组和一个酯组,其特征为乙酰乙基基组附于酯氧,而异丙氰酸酯组位于与苯环中的酯的相对位置,该化合物一般没有颜色,可与苍白黄色液体相对照,因其反应性而闻名,特别是由于异丙氰酸酯组,该组可以随时参与核循环添加反应;乙酰4-异丙氮苯甲酸酯用于各种应用,包括聚氨酯和其他聚合物的合成,以及用于生产药品和农用化学品;必须谨慎地处理该化合物,因为异丁酸盐可能具有危险性,造成呼吸刺激和敏化等风险;在与该物质打交道时,必须采取适当的安全措施,包括使用个人防护设备.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号32315-10-9 三光气 | CAS号94-09-7 对氨基苯甲酸乙酯 | CAS号503-38-8 氯甲酸三氯甲酯 | CAS号75-44-5 光气 | CAS号59096-06-9 ethyl 4-(trimet... | CAS号201230-82-2 carbon monoxide | CAS号99-77-4 对硝基苯甲酸乙酯 | CAS号23239-88-5 苯佐卡因盐酸盐 | CAS号21091-98-5 (4-甲基哌嗪-1-基)(4-... | CAS号736-40-3 ETHYL p-BENZAMI... | CAS号86764-53-6 ethyl 4-(dibenz... | CAS号69123-45-1 ethyl 4-(1,3-th... | CAS号69123-48-4 Benzoic acid,4-... | CAS号69123-49-5 Benzoic acid,4-... | CAS号69123-51-9 ethyl 4-(benzot... | CAS号69123-52-0 Benzoicacid, 4-... | CAS号69123-59-7 4-(1,3-thiazol-... | CAS号78915-40-9 4-[[3-(1-phenyl...

合成工艺路线路线简述

    苯佐卡因置于硫酸体系中,用 甲苯 作为反应溶剂,化学反应 0.5H,反应生成 乙基-4-异叠酸苯酯
    参考文献:Organosilicon Synthesis Of Isocyanates: Iii. Synthesis Of Aliphatic,Carbocyclic,Aromatic,And Alkylaromatic Isocyanatocatboxylic Acid Esters
    标题:Organosilicon Synthesis Of Isocyanates: Iii. Synthesis Of Aliphatic,Carbocyclic,Aromatic,And Alkylaromatic Isocyanatocatboxylic Acid Esters
    摘要:A Series Of Aminoacid Esters Was Prepared By Treating The Aminoacid Suspensions In Ethanol With Thionyl Chloride. Best Conversion Of Aminoacid Esters To Corresponding Isocyanates Was Achieved In The Case Of Aromatic And Carbocyclic Aminoesters By Phosgeneation Of Their N-Silyl Derivatives,And In The Case Of Aliphatic And Alkylaromatic Aminoesters By Phosgeneation Of O-Silyl Or N,O-Bissilylurethanes On Their Basis. In The Last Case Additional Step Of Esterification Of The By-Products Isocyanatoalkylcarboxylic Acid Chlorides Is Reqired After Phosgeneation. Unusual Generation Of Cynnamates And Intramolecular N-> O-Migration Of Trimethylsilyl Group In The Solutions Of Silylated Alkylaromatic Beta-Aminoacid Esters Were Found.
    DOI:10.1134/s1070363206070115

    海关参考信息

    专利信息


    专利号:WO-9847910-A1
    优先权日:1997-04-21
    标题:Method for solution phase synthesis of oligonucleotides
    发明人:PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING; HILL KEN; SMITH RANDALL S
    权利人:NEXSTAR PHARMACEUTICALS INC; PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING; HILL KEN; SMITH RANDALL S
    摘要:This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture oligonucleotides with high efficiency.

    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:EP-1200395-B1
    优先权日:1999-07-28
    标 题:Urea derivatives as inhibitors of ccr-3 receptor
    发明人:PADIA JANAK; HOCKER MICHAEL D; OHASHI HIROSHI; NISHITOBA TSUYOSHI; SAWA EIJI
    权利人:KIRIN BREWERY
    摘要:Urea and thiourea derivatives inhibit cell function of the chemokine receptor CCR-3. These compounds offer an effective means for treating a range of diseases thought to be mediated by the CCR-3 receptor. A variety of useful urea and thiourea derivatives can be synthesized using liquid and solid phase synthesis protocols.

    专利号:US-10570179-B2
    优先权日:2016-09-02
    标 题:Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
    发明人:LEE RICHARD E; ZHAO YING
    权利人:ST JUDE CHILDRENS RES HOSPITAL
    摘要:In one aspect, the invention relates to substituted urea depsipeptide analogs, derivatives thereof, and related compounds, which are useful as activators the ClpP endopeptidease; synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating infectious disease using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:US-2004106598-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds
    上海威远精细氟科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shwychem.com
    企业联系电话:021-64251386 64253204👤
    📞上海威远精细氟科技发展有限公司 ⚠️参考联系方式

    电话:021-64251386 64253204

    传真:021-64253354
    邮箱:wdchen@shwychem.com
    通信地址: 上海梅陇路130号华东理工科技大楼
    邮编: 200237
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海梅陇路130号华东理工科技大楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    天津安浩生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ahpharmatech.com
    企业联系电话:022-84840027👤
    📞天津安浩生物科技有限公司 ⚠️参考联系方式
    联系人:马经理
    电话:022-84840027

    传真:022-84840027
    邮箱:sales@ahpharmatech.com
    通信地址: 天津市东丽区四纬路10号2-201
    邮编: 300300
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市东丽区四纬路10号2-201
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.2174/1874104500701010011|10.2174/187410450701011105
    摘要:Le TC, Berlin KD, Benson SD, Eastman MA, Bell-Eunice G, Nelson AC, Benbrook DM. Heteroarotinoids with anti-cancer activity against ovarian cancer cells. Open Med Chem J. 2007 Oct 24;1():11–23.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知